Table 2.

Summary of malignant tumor data for monkeys treated with antineoplastic and immunosupressive agents

Agent	No. of monkeysa)	Route	Daily dose (mg/kg)	No. of dead with malignant tumor	Carcinogenicity
Doxorubicin hydrochloride	10	iv	0.2	0	no
Doxorubicin hydrochloride	10	iv	0.4	1	no
Doxorubicin hydrochloride	10	iv	1.0	1	no
Cyclophosphamide	23	po	6.0	1	not conclusive
Melphalan	20	ng	0.1	2	not conclusive
Procarbazine	49	sc/po, ip/po, or ip	10	17	yes
MNU	43b) or 44c)	po	10	18	yes

^a)Number of animals surviving longer than 6 months after the first dose

^b)See reference 13

^c)See refernce 5